Skip to content

Clinical research on siddha medicine Linga chenduram in the management of Suram(Fever)

SAFETY AND EFFICACY OF LINGA CHENDURAM IN THE CLINICAL MANAGEMENT OF SURAM(PYREXIA)

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2014/04/004576
Enrollment
100
Registered
2014-04-28
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- suram(pyrexia)

Interventions

Intervention1: Linga Chenduram: 65mg of Linga Chenduram will be administered orally along with honey, three times a day,for 5 days Control Intervention1: nil: nil

Sponsors

Ayothidoss pandithar hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: •Males and non pregnant females, female patients on adequate contraceptive control •Diagnosis of Suram as defined by fulfilling the symptoms increased body temperature, burning sensation of eye, body pain and nausea. •Body temperature range: 100ºF - 103 ºF •Patients giving informed consent (signed or oral witnessed, according to local regulations) before any protocol specific procedures. •Patients willing to comply with study procedures and recruitments. •Willing to intake study medication •Willing to follow diet restriction

Exclusion criteria

Exclusion criteria: •Patients receiving corticosteroids, NSAIDâ??s or antimalarial, antibiotic drugs. •Temperature more than 103 ºF and below 100ºF. •Any condition or treatment (including biologic therapies) that, in the opinion of the investigator, may place the participant at unacceptable risk during the study •Pregnant and nursing women •Terminally ill patients (or) patients with severe cardiac,hepatic (SGOT, SGPT values > 3 folds of upper limit of normal laboratory values), renal (Creatinine clearance •Patients who have already participated in a new drug study in the past 3 months.

Design outcomes

Primary

MeasureTime frame
Reducing the raised temperature by graphical dot plotting method. The onset and duration of action will be assessedTimepoint: before treatment and after treatment

Secondary

MeasureTime frame
Improving the other manifestations such as any inflammation, joint pain, etc. Reducing the intensity of joint pain and headache, on a Visual Analogue Scale (VAS) for painTimepoint: before treatment and after treatment

Countries

India

Contacts

Public ContactDrS ELANSEKARAN

NATIONAL INSTITUTE OF SIDDHA

sekarnis78@yahoo.com9962536907

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026